Curaleaf Holdings (CURLF) Cash from Discontinued Operations (2022 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Cash from Discontinued Operations of 2435000.0 for Q4 2024, down 100.58% year-over-year from 422298571.43 in Q1 2024, and down 2559.6% quarter-over-quarter from 99000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Cash from Discontinued Operations (2022 - 2024) Analysis & Trends
Curaleaf Holdings' Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 2435000.0 for Q4 2024.
- In Q4 2024, Cash from Discontinued Operations fell 100.58% year-over-year to 2435000.0; the TTM figure through Dec 2024 stood at 5503000.0 (up 65.57% YoY), while the FY2025 annual figure was 14319000.0, down 160.2% from the prior year.
- Cash from Discontinued Operations for Q4 2024 stood at 2435000.0, down from 99000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 9820868000.0 in Q2 2023, with the low at 9846000000.0 in Q1 2023.
- The 3-year median for Cash from Discontinued Operations is 557500.0 (2023), against an average of 3019800.0.
- The sharpest annual moves came in 2023 and 2024: Cash from Discontinued Operations jumped 1141.08% in 2023, then sank 176.97% in 2024.
- Curaleaf Holdings' Cash from Discontinued Operations stood at 9547000.0 in 2022, then jumped by 87.28% to 1214000.0 in 2023, then slumped by 100.58% to 2435000.0 in 2024.
- Business Quant data shows CURLF's Cash from Discontinued Operations at 2435000.0 in Q4 2024, 99000.0 in Q3 2024, and 7559167000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.44 Mn |
| Dec 31, 2024 | -2.44 Mn |
| Sep 30, 2024 | 99,000.00 |
| Sep 30, 2024 | 99,000.00 |
| Jun 30, 2024 | -7.56 Bn |
| Jun 30, 2024 | -7.56 Bn |
| Mar 31, 2024 | 7.56 Bn |
| Mar 31, 2024 | 7.56 Bn |
| Dec 31, 2023 | -1.21 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | 10.36 Mn |
| Sep 30, 2023 | 10.36 Mn |
| Jun 30, 2023 | 9.82 Bn |
| Jun 30, 2023 | 9.82 Bn |
| Mar 31, 2023 | -9.85 Bn |
| Mar 31, 2023 | -9.85 Bn |
| Dec 31, 2022 | -9.55 Mn |
| Dec 31, 2022 | -9.55 Mn |
| Sep 30, 2022 | 835,000.00 |
| Sep 30, 2022 | 835,000.00 |